BioEngineering 2017 Review

Written by Bill Whitford

Bill Whitford (GE Healthcare; IL, USA) and Alain Fairbank (most recently Director of Marketing, Cell Therapy, Danaher Corporation; DC, USA) provide their thoughts on the third annual BioEngineering 2017 (Boston, MA). Last week, SelectBIO conducted their third annual BioEngineering 2017 (MA, USA). The 2-day conference was focused on 3D bioprinting, BioMEMs, tissue engineering, and synthetic biology. During the conference, academic and industry researchers, along with industry suppliers, presented their most recent advances in these emerging fields as they come together towards the development of bio-structures and applications. The latest approaches in 3D bioprinting, including applications in the tissue engineering space...

To view this content, please register now for access

It's completely free